As the semiconductor industry enters the era of heterogeneous integration, biomedical electronics applications will certainly use related technologies for development, according to Nicky Lu, chairman of Etron Technology.
Due to the maturity of heterogeneous integration technologies, some research companies expect the output value of the semiconductor industry to grow to $1 trillion by 2030. Lu said that Taiwan's IT industry should establish close partnerships with biomedical experts to lead the world.
At present, Taiwan's semiconductor industry is the world's second or third largest semiconductor industry in terms of output value, generating about $8 billion to $9 billion annually. South Korea's semiconductor industry is worth $100 billion, and the United States is worth $150 billion.
Since Taiwan's medical industry has a good foundation and a comprehensive national health insurance system database, by combining its advantages with its competitive advantages in the semiconductor industry, Lu believes that Taiwan will become the world's top biomedical electronics industry.
There have been many experiments that combine IT technology with healthcare applications, such as using a CMOS image sensor to trigger visual signals in the brain; placing an electrode on the cochlear bone to try to help the deaf recover hearing; Lu says, implanting the chip into the patient In vivo, to detect and prevent the onset of epilepsy.
In general, because Taiwan's medical industry has a long history of research and treatment of cancer, Taiwan will likely establish a precise oncology industry through cooperation between the semiconductor and healthcare industries.